The technology is used to create an implant designed for each patient’s individual anatomy based on a three-dimensional CT scan of the patient’s knee. The trial will enroll patients who need unicompartmental knee implants due to osteoarthritis. Participants will be followed for 10 years after the procedure to determine the effectiveness of the personalized implant.
Read the report on ConforMIS.
Read Articles Related to ConforMIS:
ConforMIS Receives FDA Approval for iTotal Patient-Specific Total Knee Replacement System
10 Points on Personalized Knee Replacements
ConforMIS Releases Second Generation Knee Resurfacing System
